List of Exhibits
Exhibit 1 Segmentation of Global Healthcare-associated Infectious Disease Diagnostics Market
Exhibit 2 Market Size Calculation Approach 2018
Exhibit 3 Major Causes for the Spread of Healthcare-associated Infections
Exhibit 4 Technological Advancements in Diagnostic Tools & Assays for HAIs
Exhibit 5 Increase in Patient Population with HAIs
Exhibit 6 Growing Popularity of Molecular Diagnostic Tests for HAIs
Exhibit 7 Important Milestones in Molecular Diagnostics for Infectious Diseases
Exhibit 8 Comparison of Blood Culture Test Versus Molecular Diagnostic Test
Exhibit 9 Stringent Regulations to Prevent HAIs in Healthcare Settings
Exhibit 10 WHO’s Recommendations Using My 5 Moments for Hand Hygiene Approach
Exhibit 11 Important Recommendations for Healthcare Settings to Prevent HAIs
Exhibit 12 Availability of Sophisticated Mechanisms to Control HAIs
Exhibit 13 Steps Involved in Reprocessing Cycle of Sterile Supplies
Exhibit 14 Popular Equipment Used in Healthcare Settings to Control HAIs
Exhibit 15 Low Prevalence of HAIs in High-income Nations
Exhibit 16 Rate of HAIs in Europe (Per 1,000 population)
Exhibit 17 Strategic Acquisitions
Exhibit 18 High Growth Potential in Low and Middle-income Countries
Exhibit 19 Emerging Economies Witnessing Higher Absolute Growth in APAC
Exhibit 20 Emerging Economies Witnessing Higher Absolute Growth in Latin America
Exhibit 21 Growing Penetration of POC Tests to Diagnose HAIs
Exhibit 22 Global Healthcare-associated Infectious Disease Diagnostics Market 2018−2024 ($ million)
Exhibit 23 Five Forces Analysis 2018
Exhibit 24 Incremental Growth by Infection Type 2018–2024
Exhibit 25 Global Healthcare-associated Infections Diagnostics Market by Infection Type
Exhibit 26 Market by Infection Type 2018 & 2024 (%)
Exhibit 27 Market by Infection Type 2018−2024 ($ million)
Exhibit 28 Market by Infection Type 2018−2024 (%)
Exhibit 29 Market by Infection Type 2018-2024 (Incremental Growth)
Exhibit 30 Market by Infection Type 2018-2024 (Absolute Growth)
Exhibit 31 Global Healthcare-associated Infections Diagnostics Market by UTIs: Incremental and Absolute Growth Comparison
Exhibit 32 Risk Factors with Development of Hospital-associated UTIs
Exhibit 33 Market by UTIs 2018−2024 ($ million)
Exhibit 34 Hospital-acquired Bacteriuria in Patients with Indwelling Urethral Catheters (%)
Exhibit 35 Global Healthcare-associated Infections Diagnostics Market by SSIs: Incremental and Absolute Growth Comparison
Exhibit 36 Risk Factors of Surgical Site Infections
Exhibit 37 Market by SSIs 2018−2024 ($ million)
Exhibit 38 Global Healthcare-associated Infections Diagnostics Market by HAP: Incremental and Absolute Growth Comparison
Exhibit 39 Common Pathogens Causing HAP
Exhibit 40 Market by HAP 2018−2024 ($ million)
Exhibit 41 Host Risk Factors with Development of Multidrug-resistant Infection in HAP
Exhibit 42 Global Healthcare-associated Infections Diagnostics Market by BSI: Incremental and Absolute Growth Comparison
Exhibit 43 Market by BSI 2018−2024 ($ million)
Exhibit 44 Global Healthcare-associated Infections Diagnostics Market by GII: Incremental & Absolute Growth Comparison
Exhibit 45 Market by GII 2018−2024 ($ million)
Exhibit 46 Global Healthcare-associated Infections Diagnostics by Other Infections Incremental and Absolute Growth Comparison
Exhibit 47 Market by Other Infections 2018−2024 ($ million)
Exhibit 48 Incremental Growth by Product Type 2018–2024
Exhibit 49 Global Healthcare-associated Infections Diagnostics Market by Product Type
Exhibit 50 Market by Product Type 2018 & 2024 (%)
Exhibit 51 Market by Product Type 2018−2024 ($ million)
Exhibit 52 Market by Product Type 2018−2024 (%)
Exhibit 53 Market by Product Type 2018-2024 (Incremental Growth)
Exhibit 54 Market by Product Type 2018-2024 (Absolute Growth)
Exhibit 55 Global Healthcare-associated Infections Diagnostics Market by Consumables: Incremental and Absolute Growth Comparison
Exhibit 56 Market by Consumables 2018−2024 ($ million)
Exhibit 57 Global Healthcare-associated Infections Diagnostics Market by Analyzers/Instruments: Incremental and Absolute Growth Comparison
Exhibit 58 Market by Analyzers/Instruments 2018−2024 ($ million)
Exhibit 59 Incremental Growth by Test Type 2018−2024
Exhibit 60 Global Healthcare-associated Infections Diagnostics Market by Test Type
Exhibit 61 Market by Test Type 2018 & 2024 (%)
Exhibit 62 Market by Test Type 2018-2024 ($ million)
Exhibit 63 Market by Test Type 2018-2024 (%)
Exhibit 64 Market by Test Type 2018-2024 (Incremental Growth)
Exhibit 65 Market by Test Type 2018-2024 (Absolute Growth)
Exhibit 66 Global Traditional Healthcare-associated Infections Diagnostics Market: Incremental and Absolute Growth Comparison
Exhibit 67 Global Traditional HAI Diagnostics Market 2018−2024 ($ million)
Exhibit 68 Global Traditional HAI Diagnostics Market 2018 & 2024 (%)
Exhibit 69 Global Traditional HAI Diagnostics Market 2018−2024 ($ million)
Exhibit 70 Global Traditional HAI Diagnostics Market 2018−2024 (%)
Exhibit 71 Global Molecular Healthcare-associated Infections Diagnostics Market: Incremental and Absolute Growth Comparison
Exhibit 72 Major Advantages of Molecular Diagnostics
Exhibit 73 Market by Molecular Diagnostics 2018−2024 ($ million)
Exhibit 74 Global Molecular HAI Diagnostics Market 2018 & 2024 (%)
Exhibit 75 Global Molecular HAI Diagnostics Market 2018−2024 ($ million)
Exhibit 76 Global Molecular HAI Diagnostics Market 2018−2024 (%)
Exhibit 77 Incremental Growth by End-user Type 2018−2024
Exhibit 78 Global Healthcare-associated Infections Diagnostics Market by End-user Type
Exhibit 79 Market by End-user Type 2018 & 2024 (%)
Exhibit 80 Market by End-user Type 2018-2024 ($ million)
Exhibit 81 Market by End-user Type 2018-2024 (%)
Exhibit 82 Market by End-user Type 2018-2024 (Incremental Growth)
Exhibit 83 Market by End-user Type 2018-2024 (Absolute Growth)
Exhibit 84 Global Healthcare-associated Infections Diagnostics Market by Hospitals: Incremental and Absolute Growth Comparison
Exhibit 85 Market by Hospitals 2018−2024 ($ million)
Exhibit 86 Market by Clinics: Incremental and Absolute Growth Comparison
Exhibit 87 Market by Clinics 2018−2024 ($ million)
Exhibit 88 Market by ASCs: Incremental and Absolute Growth Comparison
Exhibit 89 Market by ASCs 2018−2024 ($ million)
Exhibit 90 Market by Other End-users: Incremental and Absolute Growth Comparison
Exhibit 91 Market by Other End-users 2018−2024 ($ million)
Exhibit 92 Incremental Growth by Geography 2018−2024
Exhibit 93 Global Healthcare-associated Infections Diagnostics Market by Geography
Exhibit 94 Market by Geography 2018 & 2024 (%)
Exhibit 95 Market by Geography 2018-2024 ($ million)
Exhibit 96 Market by Geography 2018-2024 (%)
Exhibit 97 Market by Geography 2018-2024 (Incremental Growth)
Exhibit 98 Market by Geography 2018-2024 (Absolute Growth)
Exhibit 99 Healthcare-associated Infections Diagnostics Market in North America: Incremental and Absolute Growth Comparison
Exhibit 100 Market in North America 2018–2024 ($ million)
Exhibit 101 North America Market by Test Type 2018 & 2024 (%)
Exhibit 102 North America Market by Test Type 2018–2024 ($ million)
Exhibit 103 North America Market by Test Type 2018–2024 (%)
Exhibit 104 Incremental Growth in North America 2018−2024
Exhibit 105 Market in US 2018–2024 ($ million)
Exhibit 106 Market in Canada 2018–2024 ($ million)
Exhibit 107 Healthcare-associated Infections Diagnostics Market in Europe: Incremental and Absolute Growth Comparison
Exhibit 108 Market in Europe 2018–2024 ($ million)
Exhibit 109 Europe Market by Test Type 2018 & 2024 (%)
Exhibit 110 Europe Market by Test Type 2018–2024 ($ million)
Exhibit 111 Europe Market by Test Type 2018–2024 (%)
Exhibit 112 Incremental Growth in Europe 2018−2024
Exhibit 113 Market in Germany 2018–2024 ($ million)
Exhibit 114 Market in France 2018–2024 ($ million)
Exhibit 115 Market in UK 2018–2024 ($ million)
Exhibit 116 Market in Spain 2018–2024 ($ million)
Exhibit 117 Market in Italy 2018–2024 ($ million)
Exhibit 118 Healthcare-associated Infections Diagnostics Market in APAC: Incremental and Absolute Growth Comparison
Exhibit 119 Market in APAC 2018–2024 ($ million)
Exhibit 120 APAC Market by Test Type 2018 & 2024 (%)
Exhibit 121 APAC Market by Test Type 2018–2024 ($ million)
Exhibit 122 APAC Market by Test Type 2018–2024 (%)
Exhibit 123 Incremental Growth in APAC 2018−2024
Exhibit 124 Market in Japan 2018–2024 ($ million)
Exhibit 125 Market in China 2018–2024 ($ million)
Exhibit 126 Market in India 2018–2024 ($ million)
Exhibit 127 Market in South Korea 2018–2024 ($ million)
Exhibit 128 Market in Australia 2018–2024 ($ million)
Exhibit 129 Healthcare-associated Infections Diagnostics Market in Latin America: Incremental and Absolute Growth Comparison
Exhibit 130 Market in Latin America 2018–2024 ($ million)
Exhibit 131 Latin America Market by Test Type 2018 & 2024 (%)
Exhibit 132 Latin America Market by Test Type 2018–2024 ($ million)
Exhibit 133 Latin America Market by Test Type 2018–2024 (%)
Exhibit 134 Incremental Growth in Latin America 2018−2024
Exhibit 135 Market in Brazil 2018–2024 ($ million)
Exhibit 136 Market in Mexico 2018–2024 ($ million)
Exhibit 137 Healthcare-associated Infections Diagnostics Market in MEA: Incremental and Absolute Growth Comparison
Exhibit 138 Market in MEA 2018–2024 ($ million)
Exhibit 139 MEA Market by Test Type 2018 & 2024 (%)
Exhibit 140 MEA Market by Test Type 2018–2024 ($ million)
Exhibit 141 MEA Market by Test Type 2018–2024 (%)
Exhibit 142 Incremental Growth in MEA 2018−2024
Exhibit 143 Market in Turkey 2018–2024 ($ million)
Exhibit 144 Market in South Africa 2018–2024 ($ million)
Exhibit 145 Market in Saudi Arabia 2018–2024 ($ million)
Exhibit 146 Global Healthcare-associated Infectious Disease Diagnostics Market: Vendors Market Shares
Exhibit 147 Abbott: R&D Expenditure 2016−2018 ($ million)
Exhibit 148 Abbott: Sales Breakdown by Segments in 2017−2018 ($ million)
Exhibit 149 Abbott: Sales Breakdown by Geography 2018 (%)
Exhibit 150 BD: R&D Expenditure 2016−2018 ($ million)
Exhibit 151 BD: Revenue by Business Segments 2017 & 2018 ($ million)
Exhibit 152 BD: Revenue Share by Geography (%)
Exhibit 153 Danaher: R&D Expenditure 2016−2018 ($ million)
Exhibit 154 Danaher: Revenue by Business Segments ($ billion)
Exhibit 155 Danaher: Percentage Share of Revenue by Geographies (%)
Exhibit 156 F. Hoffmann-La Roche: R&D Expenditure 2016−2018 ($ billion)
Exhibit 157 F. Hoffmann-La Roche: Revenue by Business Segments 2017−2018 ($ billion)
Exhibit 158 F. Hoffmann-La Roche: Revenue by Geographies (%)
Exhibit 159 Meridian Bioscience: R&D Expenditure 2016−2018 ($ million)
Exhibit 160 Meridian Bioscience: Revenue by Segments 2017−2018 ($ billion)
Exhibit 161 Meridian Bioscience: Revenue by Geography (%)
Exhibit 162 QIAGEN Revenue 2016−2018 ($ billion)
Exhibit 163 QIAGEN: R&D Expenditure 2016−2018 ($ million)
Exhibit 164 QIAGEN: Revenue by Segments 2017−2018 ($ billion)
Exhibit 165 QIAGEN: Revenue by Geographies
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2018
Table 3 Recent Product Approvals Related to HAI Diagnostics
Table 4 Popular Acquisitions in Hospital-acquired Infectious Disease Diagnostics Market
Table 5 Approved Diagnostic Technologies for Diagnosing Hospital-acquired UTIs
Table 6 Common Microbes Causing GI Infections
Table 7 Annual Number of Molecular Diagnostic Tests Performed for Various HAIs in 2016
Table 8 Global Healthcare-associated Infections Diagnostics Market: Vendors Ranking
Table 9 Abbott: Product Offerings
Table 10 BD: Key Product Offerings
Table 11 bioMérieux: Major Product Offerings
Table 12 Danaher: Key Product Offerings
Table 13 F. Hoffmann-La Roche: Key Product Offerings
Table 14 Meridian Bioscience: Product Offerings
Table 15 QIAGEN: Product Offerings
Table 16 Trinity Biotech: Key Product Offerings
Table 17 DiaSorin Molecular: Key Product Offerings
Table 18 OpGen: Key Product Offerings
Table 19 Accelerate Diagnostics: Key Product Offerings
Table 20 Thermo Fisher Scientific: Key Product Offerings
Table 21 Bio-Rad: Key Product Offerings
Table 22 Luminex: Key Product Offerings
Table 23 Quidel: Key Product Offerings
Table 24 Global Healthcare-associated Infections Market by Products ($ million)
Table 25 Market by Products (%)
Table 26 Global Healthcare-associated Infections Diagnostics Market by Test Type ($ million)
Table 27 Market by Test Type (%)
Table 28 Global Healthcare-associated Infections Diagnostics Market by Infection Type ($ million)
Table 29 Market by Infection Type (%)
Table 30 Global Healthcare-associated Infections Diagnostics Market by End-user Type ($ million)
Table 31 Market by End-user Type (%)
Table 32 Global Healthcare-associated Infections Diagnostics Market by Geography ($ million)
Table 33 Market by Geography (%)